Showing 20,601 - 20,620 results of 24,497 for search '(( significance ((greater disease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.49s Refine Results
  1. 20601

    The impact of nano-curcumin on cell viability and proliferation in breast cancer cells. by Taraneh Givi (22793530)

    Published 2025
    “…(C, D) MTT assays were conducted on MCF7-S and MCF7-TR cells following nano-curcumin treatment. Cell viability significantly decreased at all tested time points. (E, F) mRNA Expression levels <i>PI3K</i>, <i>AKT1</i>, <i>mTOR</i>, <i>NF-KB</i>, <i>Cyclin D1</i>, <i>DILA1</i> and <i>PTEN</i> in breast cancer cells. …”
  2. 20602

    Table 7_Evaluation of cold tolerance in sorghum germplasm from the Chishui River Basin in China: insights from germination, field trials, and physiological assays.doc by Hongli Yang (170838)

    Published 2025
    “…</p>Methods<p>We evaluated 71 sorghum germplasms at Maotai Institute from 2022 to 2024 using germination tests, pot trials, and field experiments with a two-factor design. Germination potential, germination percentage, and seedling vigor traits (plumule and radicle length and weight) varied significantly among the 71 sorghum germplasm (P < 0.01). …”
  3. 20603

    Table 5_Evaluation of cold tolerance in sorghum germplasm from the Chishui River Basin in China: insights from germination, field trials, and physiological assays.doc by Hongli Yang (170838)

    Published 2025
    “…</p>Methods<p>We evaluated 71 sorghum germplasms at Maotai Institute from 2022 to 2024 using germination tests, pot trials, and field experiments with a two-factor design. Germination potential, germination percentage, and seedling vigor traits (plumule and radicle length and weight) varied significantly among the 71 sorghum germplasm (P < 0.01). …”
  4. 20604

    Table 6_Evaluation of cold tolerance in sorghum germplasm from the Chishui River Basin in China: insights from germination, field trials, and physiological assays.doc by Hongli Yang (170838)

    Published 2025
    “…</p>Methods<p>We evaluated 71 sorghum germplasms at Maotai Institute from 2022 to 2024 using germination tests, pot trials, and field experiments with a two-factor design. Germination potential, germination percentage, and seedling vigor traits (plumule and radicle length and weight) varied significantly among the 71 sorghum germplasm (P < 0.01). …”
  5. 20605

    Table 2_The cerebral metabolic mechanism of group computer magnanimous therapy based on magnetic resonance spectroscopy: effects on improving magnanimous-enterprising levels of lun... by Qianyu Liu (7543004)

    Published 2024
    “…Significant increases in NAA/Cr levels were observed in the right amygdala, and significant decreases in mI/Cr levels were observed in the right cingulate gyrus in the GCMTG. …”
  6. 20606

    Table 1_The cerebral metabolic mechanism of group computer magnanimous therapy based on magnetic resonance spectroscopy: effects on improving magnanimous-enterprising levels of lun... by Qianyu Liu (7543004)

    Published 2024
    “…Significant increases in NAA/Cr levels were observed in the right amygdala, and significant decreases in mI/Cr levels were observed in the right cingulate gyrus in the GCMTG. …”
  7. 20607

    Table 4_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xls by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  8. 20608

    Data Sheet 1_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.doc by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  9. 20609

    Table 2_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  10. 20610

    Table 7_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  11. 20611

    Table 1_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  12. 20612

    Table 3_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  13. 20613

    Data Sheet 2_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.docx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  14. 20614

    Table 6_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  15. 20615

    Table 5_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xls by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  16. 20616

    Table 1_Redox status of biomarkers in serum of dogs with hypothyroidism and its treatment with levothyroxine sodium.docx by Ling Zhu (56356)

    Published 2025
    “…Dogs with hypothyroidism had decreased levels of serum T4 and fT4 and increased levels of serum TSH. …”
  17. 20617

    Table 2_Redox status of biomarkers in serum of dogs with hypothyroidism and its treatment with levothyroxine sodium.docx by Ling Zhu (56356)

    Published 2025
    “…Dogs with hypothyroidism had decreased levels of serum T4 and fT4 and increased levels of serum TSH. …”
  18. 20618

    Data Sheet 1_Iron improves the antiviral activity of NK cells.docx by Simone Schimmer (85325)

    Published 2025
    “…Interestingly, although iron supplementation decreased the NK cell’s cytokine production, it significantly improved NK cell degranulation and the expression of cytotoxicity-associated proteins. …”
  19. 20619

    Data Sheet 1_The impact of climate risks on green technology innovation: an empirical study based on panel data of 269 cities in China.zip by Yangyulong Wu (19867245)

    Published 2025
    “…First, the two components of climate risks—physical risks and transition risks—significantly hinder green technology innovation. Second, physical risks suppress green technology innovation by reducing market potential, while transition risks do so by decreasing foreign direct investment. …”
  20. 20620

    Data Sheet 2_Comparison with healthy controls: meta-analysis of changes in intestinal flora in Chinese patients with irritable bowel syndrome.zip by Hao Tu (16412994)

    Published 2025
    “…</p>Conclusion<p>This meta-analysis reveals gut microbiota imbalances in Chinese IBS patients: significantly increased Enterobacter and Enterococcus with decreased Lactobacillus and Bifidobacterium overall, and reduced Bacteroides specifically in IBS-D.…”